What Drove BioNTech Stock’s Incredible Rise From $80 To $420 This Year?

BioNTech, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock rally from about $80 at the end of 2020 to levels of almost $420 currently, marking an increase of about 5x. This compares to the S&P 500 which is up by just about 20% over the same period...